INTELLIA THERAPEUTICS INC (NTLA)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for NTLA
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NTLA | Member of the Board of Directors | 69 | ["Founder of Monograph Capital Partners","Co-founder of Vida Ventures","Former partner of TPG","Former professor at UCSF","Member of the board of trustees of the UCSF Foundation","Served on boards of CareDx, Inc. and Kyverna Therapeutics, Inc.","Co-founder and executive chairperson of Cell Design Labs"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Cohen served on the compensation committee throughout 2025 and on the science and technology committee throughout 2025. Our board of directors has determined that Dr. Cohen is independent as defined in the applicable SEC and Nasdaq rules.